Source: Annual Congress 2002 - Death and severe exacerbations of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Needham, D. M. Bates, H. M. Wilkins, R. A. Stockley (Birmingham, United Kingdom). Exacerbations of symptoms in alpha-1-antitrypsin deficiency in the UK. Eur Respir J 2002; 20: Suppl. 38, 1340

Member's Comments

No comment yet.

Related content which might interest you: Young adult with inherited PiMZ alpha-1-antitrypsin deficiency (A1ATD)-related bronchiectasis: characteristic of blood neutrophils and A1AT protein Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Bronchiectasis in patients with alpha1-antitrypsin deficiency: prevalence and characteristics Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments Year: 2016 Bronchiectasis in alpha1-antitrypsin deficiency Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Bronchiectasis but not emphysema is more prevalent in non-PiZ alpha-1 antitrypsin deficiency (AATD) COPD than in usual COPD Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD Year: 2014 Alpha-1 antitrypsin deficiency in patients with COPD/emphysema, bronchiectasis and asthma Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Prevalence of alpha-1-antitrypsin deficiency (A1AD) in patients with COPD. Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Alpha-1 antitrypsin deficiency in patients with bronchiectasis: data from the European Bronchiectasis Registry EMBARC Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Mortality in individuals with severe alpha-1-antitrypsin deficiency (PiZZ) Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Hereditary alpha1-antitrypsin deficiency in children and its clinical consequences Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Efficacy and safety of inhaled a1-antitrypsin in patients with severe a1-antitrypsin deficiency and frequent exacerbations of COPD Source: Eur Respir J, 54 (5) 1900673; 10.1183/13993003.00673-2019 Year: 2019 Reversible dyspnoea in alpha1-antitrypsin deficiency Source: Annual Congress 2011 - ERS Award for Rare Pulmonary Disease Ceremony (supported by GlaxoSmithKline) followed by Clinical Grand Round - an interactive session Year: 2011 Exacerbations of respiratory symptoms in COPD Source: International Congress 2019 – State of the art session: Airway disease Year: 2019 Exacerbations and duration of smoking abstinence are associated with the annual decline in lung function in individuals with PiZZ alpha-1-antitrypsin deficiency Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Smoke exposure as a determinant of autoantibody titre in alpha 1-antitrypsin deficiency and COPD Source: Eur Respir J 2011; 37: 32-38 Year: 2011 Sick euthyroid syndrome in severe COPD exacerbations Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013